Computer access to digital health information varies by race and ethnicity, a study found.
The approval was based on data from an open-label, single-arm study that evaluated the efficacy and safety of Nerivio in patients aged 12 to 17 years with migraine.
The Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to Ellume COVID-19 Home Test, the first over-the-counter (OTC) fully at-home diagnostic antigen test for coronavirus disease 2019 (COVID-19). The Ellume COVID-19 Home Test is a rapid, lateral flow antigen test developed with support from the National Institutes of Health’s Rapid Acceleration of…
Previously, the device had only been approved in those with episodic migraine.
Health checks will be done by text messages and email every day during the first week after vaccination.
ATS Virtual Program 2020
Young adults with asthma experienced improved clinical outcomes after undergoing virtual care, known as a multi-level EMR-integrated smartphone-telemedicine program.
Beginning January 1, 2021, a federal law called the Every Prescription Conveyed Securely Act takes effect requiring that prescriptions for controlled substances covered under Medicare be prescribed electronically.
The Food and Drug Administration (FDA) has cleared the Propeller Health digital platform to connect with the Symbicort® Inhaler (budesonide, formoterol fumarate dihydrate; AstraZeneca), a corticosteroid and long-acting beta-2 agonist indicated for the treatment of asthma and COPD. The Propeller platform includes a sensor that is attached to the inhaler. The sensor delivers insights on…
Higher proportion of patients using smartphones taking analgesics, getting less relief with medication.